Background: Recognition of high blood pressure (BP) in children is poor, partly due to the need to
move into adult practice, diagnosis of hypertension is less likely among younger adults (18-24 years of age) than in older patients. 12 Two key barriers to recognizing elevated BP in children are the need to determine the age-sex-height referenced BP percentiles for a given measurement and the importance of tracking BP measurements over time. We evaluated a new electronic health record-based app that extracts age, sex, height and BP data from the EHR to calculate and track a patient's BP percentile longitudinally, allowing providers the voluntary option of using this app to quickly interpret casual office BP measurements. The aim of this study was to evaluate whether provider recognition of abnormal BP (>90th percentile) differed before versus after the advent of the app and hypertension education associated with app roll-out. gallery.smarthealthit.org). 13, 14 When activated, the app displays the blood pressure percentile associated with a particular ambulatory blood pressure measurement, as well as historic blood pressure percentiles, allowing providers to determine if an elevated blood pressure represents an isolated event or if a patient has had multiple elevated blood pressures over time. The app does not provide any further recommendations regarding next steps in management. In addition, the app only uses blood pressures taken during ambulatory visits, and excludes inpatient and emergency department measurements, when blood pressure may be elevated as a result of an acute illness. BP percentiles were calculated based on the Fourth Report on the Diagnosis, Evaluation, and
| M E T H O D S
Treatment of High Blood Pressure in Children and Adolescents. 15 The application was introduced into the EHR at a large urban pediatric health center located in New England. Rollout of the application in 2012 was accompanied by 60 minute, voluntary hypertension education sessions given by cardiology and nephrology faculty to ambulatory care clinics and house staff groups. The use of the app was completely voluntary and not mandated by any incentive program.
This study was a retrospective cohort study of all well child visits in primary care clinics, as well as all non-urgent outpatient visits in the endocrinology, cardiology, and nephrology clinics that occurred in the year before and after the BP application and associated education sessions were introduced, with a 2-month window after the application was introduced to allow for provider uptake and app percolation. The population of interest was children 3-18 years of age with at least one systolic or diastolic BP reading above the 90th age-sex-height referenced percentile seen in these clinics between August, 2011 and July, 2012 (pre-app time period) or between October, 2012 and September, 2013 (post-app time period). BP measurements with no documented height within a 6-month period 3 months before or after a visit of interest were excluded. In the population of interest, we extracted data including demographic information about age, race, gender, and weight.
The exposure of interest was the time period after the app and BP education were introduced compared with the pre-app period. We performed a more in-depth analysis of 5% of the charts from the primary care clinic to determine if there was documentation of hypertension in the text of the note that did not correspond with an ICD-9 code or other form of "recognition" to determine if we may have missed recognition events using our recognition criteria.
| Analysis
The unit of analysis was individual patient visits including all visits after the initial elevated BP within the observation period until a censoring event, which was defined as either a recognition event or the end of the observation period. Therefore, the proportion of visits with elevated BP is less than 100% because BPs after an index elevated BP may have gone back into the normal range. The primary analysis compared the proportion of elevated BPs recognized between the pre-versus post-app periods using chi square testing. A secondary analysis used chi square testing to compare the pre-app period proportion recognized versus the proportion recognized in post-app patient visits where the app was actually used.
Summary statistics were used to analyze patient demographic characteristics and to determine patient factors associated with app use.
We assessed whether there were any differences in patient characteristics when the app was used versus not used by evaluating all outpatient clinical encounters, regardless of blood pressure percentile, in the year after the application was introduced to help identify predictors of app usage. Chi square analyses were used for categorical variables and t tests for continuous variables to assess whether there were differences in app use based on gender, age, height, and blood pressure percentile.
Identified predictors of app use were then incorporated into analyses of app effectiveness in order to adjust for the likelihood of using the app on the likelihood of being recognized as having elevated BP.
In order to account for possible changes in recognition over time,
we conducted an interrupted time series analysis on a monthly time scale to identify secular trends in recognition throughout the observation
period. As no secular trend was observed and an interaction term before versus after the app introduction was observed, subsequent analyses used logistic regression to identify correlates of recognition before and after the app was introduced. Multivariable adjusted logistic regression models were constructed using recognition (yes/no) as the binary outcome and pre-app, post-app with no app use, and post-app with app use as the independent variable of interest; other independent variables included age, race/ethnicity, gender, body mass index percentile, number of visits, and blood pressure percentile. We performed a sub analysis in the primary care clinics to ascertain app effect in primary pediatric practice. We performed the same multivariable logistic regression analysis on a patient level as opposed to on the level of individual encounters and found very similar, though more significant results. We used the more conservative per visit approach given that individuals seen earlier in the study period would accrue more follow up time for potential recognition as compared with those seen later in the study period. To quantify the additional predictive utility of using the app, we use receiver operator characteristics in the post-app population alone with a model constructed from multivariable clinical predictors of recognition versus those same predictors combined with app use.
All analyses were conducted using SAS version 9.2. An alpha <0.05 was considered significant. This study was approved by the Institutional Review Board at Boston Children's Hospital with a waiver of informed consent. 2910 patients during the post-app period. Baseline characteristics are given in Table 1 During the post-app period, the application was used in 5% of all encounters, and in 13% of visits with a blood pressure above the 90th percentile. Across the entire outpatient population, app use was more common for males, younger patients, and in those with higher BP, while mean BMI did not differ ( Table 2 ). The presence of BP over the 90th percentile was associated with a 1.8 (95% CI 1.6-2.0) times higher odds of using the app.
| RE SULTS
Recognition of abnormal BP in the pre-app time period occurred in 4.9% of visits, while recognition occurred in 7.1% of visits post-app (P < .001) ( Table 1) . Focusing on the post-app period, recognition when the app was used was 16.6% while when it was not used was 5.6%
( Figure 1 and Table 1 ). Recognition was primarily documented by ICD-9 code, with only a small subset of recognition being identified by ordering echocardiogram or renal ultrasound (data not shown). Controlling for predictors of app use (age, gender, race/ethnicity, BMI, and degree of blood pressure elevation), the odds ratio of recognition with app use was 3.17 (95% CI 2.29-4.41, P < .001) compared with the pre-app period (Table 3 ). In examining multivariable adjusted covariate associations, recognition was higher among males, white patients, higher BMI percentile, BP above the 95th percentile, and in cardiology and nephrology clinics (Table 3) . Post-app period recognition was most different in those patients with BP at or above the 99th percentile (Figure 2 ).
In a sub-analysis of only primary care clinics, the application was used in 15% of visits. Recognition occurred in 3% of primary care encounters. The odds or recognition was not significantly higher in the post-app period compared with the pre-app period (OR 1.67, 95% CI 0.82-3.4). In ROC curves, adding app use to the baseline predictors increased the C-statistic from 0.806 to 0.821.
| DISCUSSION
We found that use of an EHR-based application designed to aid in rec- Recognition of elevated blood pressure in children is challenging in part because the definition of an elevated blood pressure depends on a child's age, gender, and height. 15 Additionally, there are conflicting recommendations regarding whom to screen for hypertension, how often is therefore potentially related to a complex combination of factors.
The SMART BP app was designed specifically to address challenges related to determining if a BP is elevated based on a child's age, gender, and height, and to allow for quick evaluation of whether BP has been elevated over a number of visits.
Overall app usage and recognition of elevated BP was significantly associated with higher BPs, a finding that has been shown in other studies. 19 Recognition remained highest in patients with very elevated BPs, a difference that was more pronounced in the app usage group.
Even with app usage, recognition of elevated BP based on our criteria We also found that recognition was higher among male patients, white patients, and older patients in contrast to other research. 19 Uniform app availability for all outpatients did not eliminate typical healthcare disparities, although in the fully adjusted model, the effects of age and degree of blood pressure elevation were attenuated. We did not find a significant difference in recognition in the post-app period in primary care clinics, where detection of elevated BP is particularly important as this is often the first setting in which an abnormal blood pressure is identified. Further targeting of high BP recognition in the primary care setting is warranted.
Studies have shown that EHR-based tools are associated with increased recognition of elevated blood pressure in adult patients. [20] [21] [22] Similar studies in pediatrics have been limited. 23, 24 An intervention performed in primary care pediatric practices using either simplified BP tables attached to the medical chart or using a PDA tool to calculate BP percentiles was not associated with significant improvement in recognition, and uptake of the intervention tool was fairly low. 23 Another smaller, EHR-based intervention study found that automated reminders did improve in abnormal BP recognition. 24 While use of the SMART BP app was associated with significant improvement in recognition of elevated blood pressures, uptake proved similarly challenging.
We do not have specific data regarding barriers to app usage of the app, although higher voluntary app use in visits where BP was elevated is encouraging. We also found a significant increase in recognition when the app was used in our population. However, even when the app was used, the majority of elevated BP cases went unrecognized.
Although embedded within the EHR with link out to an external viewer, our tool was provider initiated and not automated into clinic workflow nor administratively mandated, instead relying on provider interest in BP on a case-by-case basis. When utilized, tools such as the SMART BP app provide a viable alternative to current practice of finding blood pressure references in tables and also highlights the potential benefit of EHR-based tools for abnormal BP recognition since the use of raw, unreferenced BP is very difficult to interpret precisely in the ambulatory setting. These tools, however, may be most useful if regularly integrated into the clinic workflow, ensuring consistent use.
This study did have some limitations. We were dependent on the BP that was recorded in the medical record; if providers recognized an elevated blood pressure and repeated a BP but did not record the repeated value in the EHR, we would have coded that individual as a missed recognition even though the provider has addressed the BP.
Our results may therefore underestimate recognition, making our
The proportion of abnormal BP recognized by height of BP elevation. Recognition rate is given along the X-axis while the BP elevation is categorized along the Y-axis as below the 95th percentile, between 95th and 98th percentiles, and over the 99th percentiles. These categories are further divided into Pre-app period, Post-app period without app used, and post-app period with app used. Error bars represent 95% confidence intervals results conservative. We conducted a more in-depth chart review of 5% of individuals seen in primary care, however, and found that documentation only in a clinical note occurred in <5% of patients, and therefore the number of repeated blood pressures documented in notes and not in the vital signs portion of the EHR was likely low.
There may have been unmeasured confounders that we did not account for in our initial design; however, we anticipate that these would have been similar in the pre-and post-app period. Much of the app use was in subspecialty clinics in which one might anticipate increased recognition of elevated BP. To maintain anonymity, cliniclevel use was captured but specific provider usage was not captured.
So we could not account for specific provider interest in blood pressure monitoring or facility with app usage. We did not assess specific diagnoses, such as chronic kidney disease or congenital heart disease, and therefore could not determine if specific diagnoses were associated with increased recognition of abnormal blood pressures, though we were able to assess for differences in primary care as opposed to subspecialty clinics, where children were more likely to carry additional diagnoses. Not every BP above the 90th percentile may need to be recognized. In this real-world practice analysis, it is prohibitively difficult to account for every variation in practice that denotes a worrisome blood pressure versus a transient BP elevation. We did account for reticence in making an ICD-9 diagnosis by including repeat visit with blood pressure measured as a criteria for recognition. But we did not have data regarding emotional state or details on technique which may impact decision making. This information gap may affect inferences on absolute rates of under recognition, but does not affect the inferences regarding app effect as such features should not have changed over time. While the propensity to use the app for the higher BPs may be viewed as biasing the analyses as a reflection that the provider already was internally sensitized to the BP, we infer the opposite. Namely since we define the criteria for recognition as externally documented clinical action and the criteria were the same before and after, we count improving the documented recognition of the highest BPs a strength of the app. Since we were interested in assessing utility of the application shortly after its rollout, our follow up time was relatively short, and we were limited to evaluating changes in recognition of elevated BP rather than changes in recognition of hypertension, which requires three separate measurements of elevated BP. 15 Finally, the study only examines the effect of voluntary, provider initiated used of the BP percentile calculator. The results of an EHR tool with better integration into clinical workflow and mandated use cannot be inferred from this data. 
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